Paper42005704
Exosomes as Emerging Nanocarriers for Targeted Cancer Therapy.
Du Y and 7 others. Int J Nanomedicine, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Exosomes as Emerging Nanocarriers for Targeted Cancer Therapy. Papers, record 42005704. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42005704
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Exosomes | Major topic |
| Neoplasms | Major topic |
| Antineoplastic Agents | Major topic |
| Drug Delivery Systems | Major topic |
| Drug Carriers | Major topic |
| Humans | |
| Animals | |
| Nanomedicine |
Source PubMed
References169
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35008083 | Construction of an exosome-functionalized graphene oxide based composite bionic smart drug delivery system and its anticancer activity. | Nanotechnology | 2022 | https://conductscience.org/library/papers/35008083 | PubMed |
| 2 | 32305351 | Extracellular vesicles as drug delivery systems: Why and how? | Adv Drug Deliv Rev | 2020 | https://conductscience.org/library/papers/32305351 | PubMed |
| 3 | 32193503 | A miRNA-based diagnostic model predicts resectable lung cancer in humans with high accuracy. | Commun Biol | 2020 | https://conductscience.org/library/papers/32193503 | PubMed |
| 4 | 37345176 | Surface-Engineered Extracellular Vesicles in Cancer Immunotherapy. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37345176 | PubMed |
| 5 | 30618806 | Extracellular Vesicles Released by Human Induced-Pluripotent Stem Cell-Derived Cardiomyocytes Promote Angiogenesis. | Front Physiol | 2018 | https://conductscience.org/library/papers/30618806 | PubMed |
| 6 | 36123730 | A review on exosomes application in clinical trials: perspective, questions, and challenges. | Cell Commun Signal | 2022 | https://conductscience.org/library/papers/36123730 | PubMed |
| 7 | 36652132 | Human umbilical cord mesenchymal stem cell-derived exosomes carrying miR-1827 downregulate SUCNR1 to inhibit macrophage M2 polarization and prevent colorectal liver metastasis. | Apoptosis | 2023 | https://conductscience.org/library/papers/36652132 | PubMed |
| 8 | 31207235 | Cyclic-recombinase-reporter mouse model to determine exosome communication and function during pregnancy. | Am J Obstet Gynecol | 2019 | https://conductscience.org/library/papers/31207235 | PubMed |
| 9 | 33277608 | Engineering precision nanoparticles for drug delivery. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33277608 | PubMed |
| 10 | 35373518 | Analysis of extracellular vesicle DNA at the single-vesicle level by nano-flow cytometry. | J Extracell Vesicles | 2022 | https://conductscience.org/library/papers/35373518 | PubMed |
| 11 | 31719241 | Circular RNAs in early brain development and their influence and clinical significance in neuropsychiatric disorders. | Neural Regen Res | 2020 | https://conductscience.org/library/papers/31719241 | PubMed |
| 12 | 37028110 | Exosomes released from U87 glioma cells treated with curcumin and/or temozolomide produce apoptosis in naive U87 cells. | Pathol Res Pract | 2023 | https://conductscience.org/library/papers/37028110 | PubMed |
| 13 | 37801930 | Peptide-graphene logic sensing system for dual-mode detection of exosomes, molecular information processing and protection. | Talanta | 2024 | https://conductscience.org/library/papers/37801930 | PubMed |
| 14 | 36354238 | Exosomes─Nature's Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics. | ACS Nano | 2022 | https://conductscience.org/library/papers/36354238 | PubMed |
| 15 | 40720624 | Translational Potential of Surface Engineered Extracellular Vesicles as Theranostic Nanocarriers in Cancer Management: Recent Developments from Bench to Bedside. | ACS Appl Bio Mater | 2025 | https://conductscience.org/library/papers/40720624 | PubMed |
| 16 | 30165139 | Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease. | J Control Release | 2018 | https://conductscience.org/library/papers/30165139 | PubMed |
| 17 | 38030054 | M2 macrophage-derived exosomes induce angiogenesis and increase skin flap survival through HIF1AN/HIF-1α/VEGFA control. | Arch Biochem Biophys | 2024 | https://conductscience.org/library/papers/38030054 | PubMed |
| 18 | 39701340 | Impact of nanoparticle properties on immune cell interactions in the lymph node. | Acta Biomater | 2025 | https://conductscience.org/library/papers/39701340 | PubMed |
| 19 | 21779028 | Molecular mechanism and physiological functions of clathrin-mediated endocytosis. | Nat Rev Mol Cell Biol | 2011 | https://conductscience.org/library/papers/21779028 | PubMed |
| 20 | 37622888 | Biogenesis, Isolation, and Detection of Exosomes and Their Potential in Therapeutics and Diagnostics. | Biosensors (Basel) | 2023 | https://conductscience.org/library/papers/37622888 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42882510 | Exosomes and Extracellular Vesicles in Oncology: Next-Generation Smart Nanocarriers for Precision Cancer Therapy. | Cells | 2026 | https://conductscience.org/library/papers/42882510 | PubMed |
| 42650187 | Curcumin-Loaded Milk-Derived Exosomes Improve the Developmental Competence of Yak Oocytes by Regulating Mitophagy. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42650187 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42005704
GET https://conductscience.org/api/papers/v1/42005704/references?page=2